Cardioxyl Pharmaceuticals Report issue

For profit Phase 2
Founded: Chapel Hill NC United States (2005)
Status: Acquired by Bristol-Myers Squibb (2015)

Organization Overview

First Clinical Trial
2009
NCT01092325
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Cardioxyl Pharmaceuticals, Inc

Active Ingredients

Drugs in Phase 2 Trials (2)

Cimlanod (2 trials)

cxl-1020 (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Heart Failure (Phase 2)

Heart Failure, Systolic (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 4
  • # of Trial APIs: 2